Literature DB >> 16557375

5-fluorouracil (5FU) treatment does not influence invasion and metastasis in microsatellite unstable (MSI-H) colorectal cancer.

Janindra Warusavitarne1, Palaniappan Ramanathan, Anthony Kaufman, Bruce G Robinson, Margaret Schnitzler.   

Abstract

Microsatellite instability is a recognised pathway of colorectal carcinogenesis responsible for about 15% of all sporadic colorectal cancers. Recent evidence has suggested that these tumours may not have the same response as microsatellite stable colon cancers to 5-fluorouracil (5FU)-based chemotherapy. The response to 5FU in four microsatellite unstable (MSI-H) cell lines was examined by cell viability assays and invasion assays. Flow cytometry was used to assess the effect of 5FU on MSI-H cell lines. In vivo response to 5FU was assessed by intraperitoneal injection of 5FU or control to 80 nude mice that had received intrasplenic injections of an MSI-H cell line KM12C prior to commencing treatment. There was inhibition of cell growth in MSI-H cell lines when treated with 5FU. There was no difference in invasiveness in the MSI-H cell lines when treated with 5FU. Primary tumours formed in 27 of the untreated and 25 of the 5FU treated mice (p=NS). There was a 36% reduction in splenic weight in those mice treated with 5FU (p<0.03). Metastases formed in 5 of the untreated and 9 of the treated mice (p=0.12). 5FU treatment of MSI-H tumours results in a reduction in growth but does not result in a reduction in invasion or metastasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16557375     DOI: 10.1007/s00384-005-0071-8

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  29 in total

1.  Microsatellite instability as a molecular marker for very good survival in colorectal cancer patients receiving adjuvant chemotherapy.

Authors:  H Elsaleh; B Shannon; B Iacopetta
Journal:  Gastroenterology       Date:  2001-04       Impact factor: 22.682

2.  Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.

Authors:  M Meyers; M W Wagner; H S Hwang; T J Kinsella; D A Boothman
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

3.  Allelic imbalance and microsatellite instability in resected Duke's D colorectal cancer.

Authors:  R Kochhar; K C Halling; S McDonnell; D J Schaid; A J French; M J O'Connell; D M Nagorney; S N Thibodeau
Journal:  Diagn Mol Pathol       Date:  1997-04

4.  Response to 5-fluorouracil of orthotopically xenografted human colon cancers with a microsatellite instability: influence of P53 status.

Authors:  M Pocard; R Bras-Gonçalves; R Hamelin; J Northover; M F Poupon
Journal:  Anticancer Res       Date:  2000 Jan-Feb       Impact factor: 2.480

5.  Peripheral blood mononuclear cells are a reliable internal standard for the flow cytometric DNA analysis of frozen malignant breast biopsies.

Authors:  D E Benn; B G Robinson
Journal:  Cytometry       Date:  1996-06-15

Review 6.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

Review 7.  Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors.

Authors:  S Cascinu; V Georgoulias; D Kerr; T Maughan; R Labianca; M Ychou
Journal:  Ann Oncol       Date:  2003       Impact factor: 32.976

8.  Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.

Authors:  Min Yao; Stacia Kargman; Eugene C Lam; Colleen R Kelly; Yaxin Zheng; Pauline Luk; Elizabeth Kwong; Jilly F Evans; M Michael Wolfe
Journal:  Cancer Res       Date:  2003-02-01       Impact factor: 12.701

9.  Molecular pharmacology of cancer therapy in human colorectal cancer by gene expression profiling.

Authors:  Paul A Clarke; Mark L George; Sandra Easdale; David Cunningham; R Ian Swift; Mark E Hill; Diana M Tait; Paul Workman
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

10.  The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells.

Authors:  D Fink; S Nebel; P S Norris; S Aebi; H K Kim; M Haas; S B Howell
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

View more
  4 in total

1.  Multi-Domain Photopatterned 3D Tumor Constructs in a Micro-Physiological System for Analysis, Quantification, and Isolation of Infiltrating Cells.

Authors:  Shiny A P Rajan; Aleksander Skardal; Adam R Hall
Journal:  Adv Biosyst       Date:  2020-02-25

2.  Large proportion of low frequency microsatellite-instability and loss of heterozygosity in pheochromocytoma and endocrine tumors detected with an extended marker panel.

Authors:  Susan Kupka; Birgit Haack; Marty Zdichavsky; Tanja Mlinar; Christine Kienzle; Thomas Bock; Reinhard Kandolf; Stefan-Martin Kroeber; Alfred Königsrainer
Journal:  J Cancer Res Clin Oncol       Date:  2007-09-08       Impact factor: 4.553

3.  Intravital imaging of the effects of 5-fluorouracil on the murine liver microenvironment using 2-photon laser scanning microscopy.

Authors:  Masato Okigami; Koji Tanaka; Yasuhiro Inoue; Susumu Saigusa; Yoshinaga Okugawa; Yuji Toiyama; Yasuhiko Mohri; Masato Kusunoki
Journal:  Oncol Lett       Date:  2016-02-23       Impact factor: 2.967

4.  The MACC1-SPON2 axis: a new biomarker and therapeutic target in colorectal cancer.

Authors:  P Chandrasinghe; J Stebbing; J Warusavitarne
Journal:  Oncogene       Date:  2016-09-26       Impact factor: 9.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.